Published in AJR Am J Roentgenol on March 01, 2002
Accuracy of ultrasound-guided, large-core needle breast biopsy. Eur Radiol (2008) 0.96
Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients. Eur Radiol (2005) 0.92
Ultrasound-guided vacuum-assisted breast biopsy using Mammotome biopsy system for detection of breast cancer: results from two high volume hospitals. Int J Clin Exp Med (2014) 0.75
Ductal carcinoma in situ diagnosed using an ultrasound-guided 14-gauge core needle biopsy of breast masses: can underestimation be predicted preoperatively? Ultrasonography (2014) 0.75
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. Radiology (2012) 3.36
Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol (2010) 2.97
Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol (2010) 2.89
Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol (2008) 2.77
A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J (2005) 2.71
Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology (2011) 2.41
The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy. Ann Surg (2010) 2.26
Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med (2010) 2.17
Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. AJR Am J Roentgenol (2006) 2.11
Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin (2002) 2.07
Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J (2005) 2.04
The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. J Am Coll Surg (2003) 1.88
MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol (2003) 1.84
Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Ann Surg Oncol (2013) 1.84
Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology (2011) 1.74
Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up. Am J Surg Pathol (2011) 1.68
Preoperative MR imaging-guided needle localization of breast lesions. AJR Am J Roentgenol (2002) 1.66
Eighteen sensations after breast cancer surgery: a 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Ann Surg Oncol (2007) 1.66
To excise or to sample the mammographic target: what is the goal of stereotactic 11-gauge vacuum-assisted breast biopsy? AJR Am J Roentgenol (2002) 1.64
Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol (2007) 1.63
Acupuncture in the treatment of upper-limb lymphedema: results of a pilot study. Cancer (2013) 1.62
MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol (2003) 1.62
Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol (2008) 1.60
The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo. Proc Natl Acad Sci U S A (2008) 1.53
Screening breast MR imaging in women with a history of chest irradiation. Radiology (2011) 1.53
Minimally invasive breast surgery. J Am Coll Surg (2004) 1.50
MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol (2003) 1.50
Cancellation of MR imaging-guided breast biopsy due to lesion nonvisualization: frequency and follow-up. Radiology (2011) 1.44
Dynamic NMR effects in breast cancer dynamic-contrast-enhanced MRI. Proc Natl Acad Sci U S A (2008) 1.41
Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol (2002) 1.40
MRI-guided 9-gauge vacuum-assisted breast biopsy: initial clinical experience. AJR Am J Roentgenol (2005) 1.40
Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol (2007) 1.38
Long-term outcomes in breast cancer patients undergoing immediate 2-stage expander/implant reconstruction and postmastectomy radiation. Cancer (2011) 1.38
Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology (2003) 1.34
Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg (2002) 1.32
Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin (2002) 1.32
A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg (2007) 1.24
Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology (2012) 1.22
Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology (2006) 1.21
Desmoid tumors (fibromatoses) of the breast: a 25-year experience. Ann Surg Oncol (2007) 1.21
Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol (2005) 1.20
Perpendicular inked versus tangential shaved margins in breast-conserving surgery: does the method matter? J Am Coll Surg (2007) 1.17
Breast MRI screening of women with a personal history of breast cancer. AJR Am J Roentgenol (2010) 1.17
Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging. Radiology (2011) 1.17
Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? Cancer (2010) 1.14
Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. AJR Am J Roentgenol (2011) 1.14
Fast MRI-guided vacuum-assisted breast biopsy: initial experience. AJR Am J Roentgenol (2003) 1.13
Imaging breast cancer. Radiol Clin North Am (2007) 1.13
Ductal enhancement on MR imaging of the breast. AJR Am J Roentgenol (2003) 1.12
Mammographic surveillance after breast conservation therapy. Radiology (2013) 1.09
Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol (2002) 1.09
Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy. Radiology (2007) 1.07
Ensuring high-quality breast MR imaging technique and interpretation. Radiology (2013) 1.07
Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy? AJR Am J Roentgenol (2006) 1.07
Chondral defect repair after the microfracture procedure: a nonhuman primate model. Am J Sports Med (2005) 1.06
Age-related longitudinal changes in depressive symptoms following breast cancer diagnosis and treatment. Breast Cancer Res Treat (2013) 1.06
Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma. J Magn Reson Imaging (2013) 1.05
Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol (2005) 1.04
Radioactive seed localization with 125I for nonpalpable lesions prior to breast lumpectomy and/or excisional biopsy: methodology, safety, and experience of initial year. Health Phys (2013) 1.00
Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging. Breast J (2012) 1.00
Explaining age-related differences in depression following breast cancer diagnosis and treatment. Breast Cancer Res Treat (2012) 0.99
Targeted ultrasound of the breast in women with abnormal MRI findings for whom biopsy has been recommended. AJR Am J Roentgenol (2009) 0.98
Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. Eur Radiol (2012) 0.98
Safety and efficacy of radioactive seed localization with I-125 prior to lumpectomy and/or excisional biopsy. Eur J Radiol (2013) 0.96
Nonpalpable mammographically occult invasive breast cancers detected by MRI. AJR Am J Roentgenol (2006) 0.96
Postmastectomy intensity modulated radiation therapy following immediate expander-implant reconstruction. Radiother Oncol (2010) 0.96